Lidocaine induces the ferroptosis of ovarian and breast cancers by increasing miR-382-5p and decreasing SLC7A11 [105], while ketamine induces ferroptosis by targeting the KAT5/GPX4 axis in breast cancer cells [106]. Here, KAT5 is linked to breast carcinoma.